GHRH AnalogHover to zoomQualified Research Reference
CJC-1295 with DAC
CJC-1295 with DAC is documented for controlled research models and literature-based evaluation only.
- Regular
- $149.99
- Elite Member−10%
- $134.99
CJC-1295 with DAC is a high-purity research compound supplied for controlled laboratory and analytical investigation. Manufactured to a research-grade specification.
Common areas of investigation include receptor signaling, cellular pathway modeling, and compound-specific analytical research.
Research Use Only. This product is intended exclusively for laboratory research and is not approved for human or veterinary use.
CJC-1295 with DAC: investigational profile.
Research Mechanism
The DAC (Drug Affinity Complex) form of CJC-1295, engineered for extended plasma half-life via albumin binding, investigated for sustained GHRH-receptor engagement. Ipamorelin is the standard partner in combined-axis protocols.
Investigational Profile
Sustained-release GHRH-analog research emerged in the mid-2000s and remains active in endocrine-axis literature.
Research Study Window
Extended half-life shifts observation windows toward six- to twelve-week arms, capturing steady-state pulsatile release across the study period.
Pairs With
Ipamorelin
Ingredients, disclosed.
Every compound and formulation strength documented without proprietary blends.
